Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone

Published:2009-01 Issue:1 Volume:20 Page:121-128
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Kim B.-S.,Kim D.-W.,Im S.-A.,Kim C.W.,Kim T.-Y.,Yoon S.-S.,Heo D.S.,Bang Y.-J.,Park S.,Kim B.K.,Kim N.K.

Funder

Korea Health 21 R&D Project

Ministry of Health & Welfare

Innovative Research Institute for Cell Therapy

Republic of Korea

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/20/1/121/308218/mdn551.pdf

Reference34 articles.

1. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm;Chan;Blood,1997

2. Detection of Epstein-Barr virus RNA in malignant lymphomas of the upper aerodigestive tract;Chan;Am J Surg Pathol,1994

3. Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection;Arber;Am J Surg Pathol,1993

4. REAL classification of malignant lymphomas in the republic of korea

5. Report of the Workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology;Jaffe;Am J Surg Pathol,1996

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data;Frontiers in Oncology;2024-07-31

2. Treatment of extranodal NK/T-cell lymphoma: From past to future;Frontiers in Immunology;2023-02-07

3. High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma;Pharmaceuticals;2022-10-26

4. A new conditioning regimen with chidamide, cladribine, gemcitabine and busulfan significantly improve the outcome of high‐risk or relapsed/refractory non‐Hodgkin 's lymphomas;International Journal of Cancer;2021-08-25

5. Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell Lymphoma;Frontiers in Oncology;2020-08-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3